<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Tokyo_Tech_Project_Artificial_Cooperation_System"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Tokyo_Tech/Project/Artificial_Cooperation_System&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Artificial_Cooperation_System&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Artificial_Cooperation_System&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Tokyo_Tech/Project/Artificial_Cooperation_System" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Tokyo Tech/Project/Artificial Cooperation System</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2010.igem.org</H3><P><TITLE>
       iGEM Tokyo Tech 2010 &quot;E.coli with Humanity&quot;
       </TITLE></P><DIV id="main_wrapper"><DIV id="header"><DIV id="navigation"><DIV id="menu" style="position:static"><UL><LI id="mainHome"><A class="aMain" href="https://2010.igem.org/Team:Tokyo_Tech">Home</A></LI><LI id="mainProject"><A class="aProject">Project menu</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech">1 Graphic abstract</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech#Apple repotrers">2 Apple Reporter</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter">   2-1 Color</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter2">   2-2 Fragrance</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System">3 Artificial Cooperation System</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/lux_act_rep">   3-1 lux activation/repression part</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/Cm_assay">   3-2 Resistance gene activaion device</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/luxI_assay">   3-3 luxI Assay</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling">   3-4 Modeling</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli">4 wolfcoli</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/New_Series_of_PompC">   4-1 PompC</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/lacIM1">   4-2 lacIM1</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/System">   4-3 wolfcoli system</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Acknowledgement">Acknowledgements</A></LI></UL><LI id="mainParts"><A class="aParts" href="https://2010.igem.org/Team:Tokyo_Tech/Parts">Parts</A></LI><LI id="mainModeling"><A class="aModeling" href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling">Modeling</A></LI><LI id="mainTeam"><A class="aTeam" href="https://2010.igem.org/Team:Tokyo_Tech/Team">Team</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team">Overview</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team#Students">Students</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team#Faculty Instructors">Faculty Instructors</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team_history">Previous Tokyo Tech Teams</A></LI><LI id="mainSponsors"><A class="aSponsors" href="https://2010.igem.org/Team:Tokyo_Tech/Sponsors">Sponsors</A></LI><LI id="mainProject"><A class="aCriteria">For judging form</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Parts">Parts</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/safety">Safety</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Collaboration">Collaboration</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Attribution_contributions">Attribution and Contributions</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Comments">Comments</A></LI><LI id="mainSitemap"><A class="aSitemap" href="https://2010.igem.org/Team:Tokyo_Tech/Project">Sitemap</A></LI></DIV></DIV></DIV></DIV><DIV id="super_main_wrapper"><DIV id="tf_menu"><FONT size="5" color="#eb8300"><CENTER><B>Project menu</B></CENTER></FONT><CENTER><TABLE id="table-01"><TBODY><TR><TD><A href="/Team:Tokyo_Tech" title="Team:Tokyo Tech">1 Graphic abstract</A></TD></TR><TR><TD>2 Apple reporter<DL><DD><A href="/Team:Tokyo_Tech/Project/Apple_Reporter" title="Team:Tokyo Tech/Project/Apple Reporter">2-1 Color</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Apple_Reporter2" title="Team:Tokyo Tech/Project/Apple Reporter2">2-2 Fragrance</A></DD></DL></TD></TR><TR><TH>3 Artificial Cooperation System            -YOU ARE HERE!-<DL><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/lux_act_rep" title="Team:Tokyo Tech/Project/Artificial Cooperation System/lux act rep">3-1 <I>lux</I> activation/repression promoter</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/Cm_assay" title="Team:Tokyo Tech/Project/Artificial Cooperation System/Cm assay">3-2 resistance gene activation device</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/luxI_assay" title="Team:Tokyo Tech/Project/Artificial Cooperation System/luxI assay">3-3 <I>lux</I>I Assay</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling" title="Team:Tokyo Tech/Project/Artificial Cooperation System/modeling">3-4 modeling</A></DD></DL></TH></TR><TR><TD><A href="/Team:Tokyo_Tech/Project/wolf_coli" title="Team:Tokyo Tech/Project/wolf coli">4 Wolf coli overview</A><DL><DD><A href="/Team:Tokyo_Tech/Project/wolf_coli/New_Series_of_PompC" title="Team:Tokyo Tech/Project/wolf coli/New Series of PompC">4-1 New seriesof P<I>ompC</I></A></DD><DD><A href="/Team:Tokyo_Tech/Project/wolf_coli/lacIM1" title="Team:Tokyo Tech/Project/wolf coli/lacIM1">4-2 lacIM1 for band-detect network </A></DD><DD><A href="/Team:Tokyo_Tech/Project/wolf_coli/System" title="Team:Tokyo Tech/Project/wolf coli/System">4-3 Wolf coli system</A></DD></DL></TD></TR></TBODY></TABLE></CENTER></DIV><DIV id="tf_SubWrapper"><P><FONT size="5"><B>3 Artificial Cooperation System</B></FONT></P><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Artificial_Cooperation_System"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Artificial Cooperation System</SPAN></A></LI><LI class="toclevel-1 tocsection-2"><A href="#Abstract"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Abstract</SPAN></A></LI><LI class="toclevel-1 tocsection-3"><A href="#Introduction"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">Introduction</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#What.E2.80.99s_Artificial_Cooperation_System.3F"><SPAN class="tocnumber">3.1</SPAN><SPAN class="toctext">What’s Artificial Cooperation System?</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#Genetic_Circuit"><SPAN class="tocnumber">3.2</SPAN><SPAN class="toctext">Genetic Circuit</SPAN></A></LI></UL><LI class="toclevel-1 tocsection-6"><A href="#Result"><SPAN class="tocnumber">4</SPAN><SPAN class="toctext">Result</SPAN></A></LI><LI class="toclevel-2 tocsection-7"><A href="#LuxR_repression_promoter_and_activation_promoter"><SPAN class="tocnumber">4.1</SPAN><SPAN class="toctext">LuxR repression promoter and activation promoter</SPAN></A></LI><LI class="toclevel-2 tocsection-8"><A href="#Chloramphenicol_resistance_geneator_activated_by_LuxR"><SPAN class="tocnumber">4.2</SPAN><SPAN class="toctext">Chloramphenicol resistance geneator activated by LuxR</SPAN></A></LI><LI class="toclevel-2 tocsection-9"><A href="#LuxI_can_produce_sufficient_3OC6HSL_to_activate_LuxR_activation_promoter"><SPAN class="tocnumber">4.3</SPAN><SPAN class="toctext">LuxI can produce sufficient 3OC6HSL to activate LuxR activation promoter</SPAN></A></LI><LI class="toclevel-2 tocsection-10"><A href="#Mathematical_modeling"><SPAN class="tocnumber">4.4</SPAN><SPAN class="toctext">Mathematical modeling</SPAN></A></LI><LI class="toclevel-1 tocsection-11"><A href="#Conclusion"><SPAN class="tocnumber">5</SPAN><SPAN class="toctext">Conclusion</SPAN></A></LI></TD></TR></TBODY></TABLE><H1><SPAN class="mw-headline" id="Artificial_Cooperation_System">Artificial Cooperation System</SPAN></H1><H1><SPAN class="mw-headline" id="Abstract">Abstract</SPAN></H1><P>We built Artificial Cooperation System to endow E.coli with humanity. In this system quorum sensing system and chloramphenicol resistance protein generator activated by LuxR are very important. First, we constructed and characterized several promoters regulated by LuxR and 3OC6HSL. We designed and constructed a new LuxR repression promoter. Also, we characterized the functions of a LuxR repression promoter and a LuxR activation promoter in the registry. Second, we constructed a new chloramphenicol resistance protein generator which is regulated by LuxR activation promoter. We confirmed that the cell with the chloramphenicol resistance protein generator can survive under high concentration of chloramphenicol when 3OC6HSL exists. Third, we confirmed that LuxI can produce sufficient 3OC6HSL to activate chloramphenicol resistance gene. Forth, we confirmed the feasibility of Artificial Cooperation System from simulation and experimental data.
</P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">fig.3-1-1   luxR activation promoter assay   (worked by Kitano Shohei &amp; Eriko Uchikoshi)</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">fig.3-1-3   luxR repression promoter assay   (worked by Shohei Kitano &amp; Eriko Uchikoshi)</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig3-2-1  Chloramphenicol resistance device. This work done by Yusuke Kaneta</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig3-3-1 LuxI and LuxR activation promoter assay. This work done by Eriko Uchikoshi and Shohei Kitano</DIV></DIV></DIV><H1><SPAN class="mw-headline" id="Introduction">Introduction</SPAN></H1><H2><SPAN class="mw-headline" id="What.E2.80.99s_Artificial_Cooperation_System.3F">What’s Artificial Cooperation System?</SPAN></H2><P>Artificial Cooperation System was built to engineer <I>E. coli</I> that behaves kindly and have sympathy. In our idea of <I>E. coli</I> with humanity,  there are two types of cells. In normal conditions, they are competitors for survival. While in critical conditions, such that one is dying, another cell would notice the crisis of dying cell and help her. For realization of our idea, we constructed a system that named  “Artificial Cooperation System”.
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:642px;"><DIV class="thumbcaption">Fig 3-0-1.They are competitors. 2.One is dying, another cell notices it. 3.The healthy cell rescues the dying cell. 4. The dying cell recovers and she gives &quot;Apples&quot; as expression of appreciation</DIV></DIV></DIV></DIV><H2><SPAN class="mw-headline" id="Genetic_Circuit">Genetic Circuit</SPAN></H2><P>We designed the following circuit. In Artificial Cooperation System, there are two types of <I>E. coli</I>, Cell A and Cell B. Cell A has resistance to kanamycin and Cell B has resistance to chloramphenicol originally. In cell A (Fig 3-0-2), production of LasI is repressed by LuxR/3OC6HSL complex and chloramphenicol resistance gene is activated by LuxR/3OC6HSL complex. In cell B (Fig3-0-3), production of LuxI is repressed by LasR/3OC12HSL complex and kanamycin resistance gene is activated by LasR/3OC12HSL complex. This means that 3OC12HSL produced by cell A and 3OC6HSL produced by cell B indirectly repress each other’s production. On the other hand, 3OC12HSL activates resistance gene of cell B and 3OC6HSL activates resistance gene of cell A.  Apple gene is composed of crtEBIYZW and MpAAT1. This expresses only when the cell is rescued and recovered.
</P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig3-0-2.Genetic circuit in cell A</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig3-0-3.Genetic circuit in cell B</DIV></DIV></DIV><P>
Pcon: constitutive promoter.
Plux act: promoter activated by LuxR and 3OC6HSL. We call this promoter luxR activation promoter.
Plux rep: promoter repressed by LuxR and 3OC6HSL. We call this promoter luxR repression promoter.
Plas act: promoter activated by LasR and 3OC12HSL. We call this promoter lasR activation promoter.
Plas rep: promoter repressed by LasR and 3OC12HSL. We call this promoter lasR repression promoter.
lasI: enzyme repressed by LuxR and 3OC6HSL. We call this promoter LuxR repression promoter.
luxI: enzyme repressed by LasR and 3OC12HSL. We call this promoter LasR repression promoter.</P><P><FONT size="4">Normal</FONT></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig3-0-4. Normal condition</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig3-0-5. Normal condition</DIV></DIV></DIV><P>In normal situation, Cell A and Cell B are competitors and recognize each other by using quorum sensing. First, LasI protein in Cell A produces 3OC12HSL. Second, these signal molecules diffuse through cell membranes and bind to LasR protein in Cell B. Third, LasR/3OC12HSL complex represses the production of LuxI protein. Similarly in cell B, LuxI protein produces 3OC6HSL. These signal molecules diffuse through cell membranes and bind to LuxR protein in Cell A. LuxR/3OC6HSL complex represses the production of LasI protein. Although Cell A and Cell B have chloramphenicol and kanamycin resistance gene respectively, they don’t express in this situation. This is because the concentration of 3OC12HSL and 3OC6HSL is too low to activate the expressions of kanamycin resistance gene and chloramphenicol resistance gene, respectively.</P><P><FONT size="4"> when Cell A is dying </FONT></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig 3-0-6. Cell A is dying.</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig 3-0-7. Cell A is dying.</DIV></DIV></DIV><P>
As we mentioned, originally Cell A has a resistance gene against kanamycin and does not have that against chloramphenicol. On the other hand, Cell B has resistance to chloramphenicol and doesn’t have resistance to kanamycin. Therefore, the addition of chloramphenicol only decreases the number of Cell A.  It means that 3OC12HSL decreases. It also results in the decrease of LasR/3OC12HSL complex that repress the expression of LasI in Cell B. By this process, Cell B notices that Cell A is dying and tries to rescue it.</P><P><FONT size="4"> when Cell B tries to rescue Cell A </FONT></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig 3-0-8. Cell B is trying to rescue cell A</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig 3-0-9. Cell B is trying to resucue cell A</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig 3-0-10. Cell A is rescued by cell B.</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig 3-0-11. Cell A is rescued by cell B.</DIV></DIV></DIV><P>As we mentioned, the expression of <I>luxI</I> is repressed by LasR/3OC12HSL complex. Therefore, the decrease of 3OC12HSL/LasR complex causes the overexpression of <I>luxI</I> and the increase of 3OC6HSL. This results in the expression of chloramphenicol resistance gene in the Cell A. Consequently, the Cell A is recovered and begins to produce the apple reporters in return!
</P><H1><SPAN class="mw-headline" id="Result">Result</SPAN></H1><P>In order to make the Artificial Cooperation System, we constructed and characterized several important parts and devices.  First we characterized LuxR repression promoter R0061 and activation promoter R0062, both of which are existing parts. Second, we designed and characterized a new LuxR repression promoter <A href="http://partsregistry.org/Part:BBa_K395008" class="external text" rel="nofollow">K395008</A>. Third, we designed and characterized a NEW BioBrick device <A href="http://partsregistry.org/Part:BBa_K395162" class="external text" rel="nofollow">K395162</A>, a chloramphenicol resistance generator, which is activated by a LuxR activation promoter. Forth, we confirmed that LuxI can produce sufficient AHL to help dying cell. Finally, we simulated our Artificial Cooperation System and confirmed the feasibility of our system.
</P><H2><SPAN class="mw-headline" id="LuxR_repression_promoter_and_activation_promoter"> LuxR repression promoter and activation promoter</SPAN></H2><P>We characterized LuxR repression promoters and activation promoters, which play important roles in the Artificial Cooperation System. The following figures are the result of experiments. Fig3-1-1 shows that under the regulations by R0062 (LuxR activation promoter), GFP expression was activated in the presence of 3OC6HSL. Fig3-1-3 shows that under the regulations by R0061 and K395008, GFP expressions were repressed in the presence of 3OC6HSL. Also, for realization of the Artificial Cooperative System work, the strength and the threshold of these promoters are so important. Thus we tried tuning promoters by changing sequence of consensus -35/-10 and lux box.  <A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/lux_act_rep" title="Team:Tokyo Tech/Project/Artificial Cooperation System/lux act rep">(See more…)</A></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">fig.3-1-1   luxR activation promoter assay   (worked by Kitano Shohei &amp; Eriko Uchikoshi)</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">fig.3-1-3   luxR repression promoter assay   (worked by Shohei Kitano &amp; Eriko Uchikoshi)</DIV></DIV></DIV><H2><SPAN class="mw-headline" id="Chloramphenicol_resistance_geneator_activated_by_LuxR">Chloramphenicol resistance geneator activated by LuxR</SPAN></H2><P>We succeeded in construction and characterization of a NEW Biobrick device of a chloramphenicol resistance (<I>CmR</I>) generator 
(<A href="http://partsregistry.org/Part:BBa_K395162" class="external text" rel="nofollow">BBa_K395162</A>) which is activated by LuxR activation promoter. Fig 3-2-1 shows that in the presence of 3OC6HSL, the device is activated and as a result the cell was able to survive under high chloramphenicol concentration (750 ug/ml). <A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/Cm_assay" title="Team:Tokyo Tech/Project/Artificial Cooperation System/Cm assay">(See more…)</A></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig3-2-1  Chloramphenicol resistance device. This work done by Yusuke Kaneta</DIV></DIV></DIV><H2><SPAN class="mw-headline" id="LuxI_can_produce_sufficient_3OC6HSL_to_activate_LuxR_activation_promoter">LuxI can produce sufficient 3OC6HSL to activate LuxR activation promoter</SPAN></H2><P>We constructed a new LuxI generator (<A href="http://partsregistry.org/Part:BBa_K395146" class="external text" rel="nofollow">BBa_K395146</A>) and characterized its function.  By combining I14032 (PlacI<SUP>q</SUP>) and K092400 (rbs-luxI-ter), we constructed K395146.  Then we confirmed that the cell with K395146 produced the sufficient amount of 3OC6HSL to activate LuxR activation promoter (R0062) <A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/luxI_assay" title="Team:Tokyo Tech/Project/Artificial Cooperation System/luxI assay">(See more…)</A></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Fig3-3-1 LuxI and LuxR activation promoter assay. This work done by Eriko Uchikoshi and Shohei Kitano</DIV></DIV></DIV><H2><SPAN class="mw-headline" id="Mathematical_modeling">Mathematical modeling</SPAN></H2><P>In order to confirm the feasibility of the Artificial Cooperation System, we simulated the system under typical four experimental conditions. First, when the system worked and any antibiotics did not exist, cell A and cell B in the system showed no difference of growth (Fig.3-0-2). Second, when the system did not work and chloramphenicol existed, the number of cell A decreased while the number of cell B increased (Fig.3-0-3). Third, when the system worked and chloramphenicol existed, the number of cell A increased after temporal decline (Fig.3-0-4), which means it was rescued by Artificial Cooperation System. Fourth, in the contrast, when the system worked and kanamycin existed, the number of cell B increased after temporal decline (Fig.3-0-5). From the above results, the feasibility of the Artificial Cooperation System was confirmed.<A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling" title="Team:Tokyo Tech/Project/Artificial Cooperation System/modeling">(See more…)</A></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig3-0-2 Simulation result in absence of antibiotics. This work done by Shohei Kitano</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig3-0-3 Simulation result without Artificial Cooperation System. This work done by Shohei Kitano</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig3-0-4 Simulation result in the presence of chloramphenicol. This work done by Shohei Kitano</DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fog3-0-5 Simulation result in the presence of kanamycin. This work done by Shohei Kitano</DIV></DIV></DIV><H1><SPAN class="mw-headline" id="Conclusion">Conclusion</SPAN></H1><P>We succeeded in constructing two new BioBrick, LuxR repression promoter (K395008) and chloramphenicol resistance gene generator activated by LuxR and 3OC6HSL. We characterized existing LuxR repression promoter and LuxR activation promoter in the registry. From the experimental data and simulation result, we confirmed the feasibility of the Artificial Cooperation System, <I>E. coli</I> with humanity.
</P></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System">http://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Tokyo_Tech/Project/Artificial_Cooperation_System" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Tokyo_Tech/Project/Artificial_Cooperation_System" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Artificial_Cooperation_System&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Artificial_Cooperation_System&amp;oldid=208536" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2010.igem.org:Privacy_policy" title="2010.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2010.igem.org:General_disclaimer" title="2010.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>